UBERDOC Health Technologies Corp.
ESVNF
$0.38
$0.1460.82%
OTC PK
| 01/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 48.01% | 268.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 45.50% | 268.08% | |||
| Operating Income | -45.50% | -256.35% | |||
| Income Before Tax | 348.14% | -2,199.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 348.14% | -2,199.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 348.14% | -2,199.86% | |||
| EBIT | -45.50% | -256.35% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 347.73% | -1,876.79% | |||
| Normalized Basic EPS | -20.73% | -19,671.43% | |||
| EPS Diluted | 347.73% | -1,876.79% | |||
| Normalized Diluted EPS | -20.73% | -19,671.43% | |||
| Average Basic Shares Outstanding | 0.00% | 16.60% | |||
| Average Diluted Shares Outstanding | 0.00% | 16.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||